drugset / Trial / NCT00926809

H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection

NCT00926809

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the effect of Helicobacter pylori eradication therapy on the healing of iatrogenic gastric ulcer caused by endoscopic mucosal resection of gastric neoplastic lesions and is a multicenter, randomized, double blind, and placebo controlled trial.

Timeline

Start
2008-09
Primary completion
2010-09
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 1000 mg
Comparator Clarithromycin Small molecule 500 mg
Comparator Lansoprazole Other / unclassified

Indications